Trademark: 86178806
Status Date
Friday, October 8, 2021
Registration Number
4697113
Registration Date
Tuesday, March 3, 2015
Filing Date
Wednesday, January 29, 2014
Published for Opposition
Tuesday, June 10, 2014
Cancellation Date
Friday, October 8, 2021
42 Conducting clinical trials for others on the safety and effectiveness of drugs; conducting clinical trials on the safety and effectiveness of apremilast; conducting clinical trials for others on the safety and effectiveness of drugs for psoriasis; providing medical and scientific research information in the field of clinical trials
Oct 8, 2021
Cancelled Sec. 8 (6-Yr)
Mar 3, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 28, 2015
Teas Change Of Correspondence Received
Mar 3, 2015
Registered-Principal Register
Jan 28, 2015
Notice Of Acceptance Of Statement Of Use E-Mailed
Jan 27, 2015
Allowed Principal Register - Sou Accepted
Jan 7, 2015
Statement Of Use Processing Complete
Nov 13, 2014
Use Amendment Filed
Dec 15, 2014
Case Assigned To Intent To Use Paralegal
Nov 13, 2014
Teas Statement Of Use Received
Aug 5, 2014
Noa E-Mailed - Sou Required From Applicant
Jun 10, 2014
Official Gazette Publication Confirmation E-Mailed
Jun 10, 2014
Published For Opposition
May 21, 2014
Notification Of Notice Of Publication E-Mailed
May 1, 2014
Approved For Pub - Principal Register
Apr 30, 2014
Assigned To Examiner
Feb 10, 2014
New Application Office Supplied Data Entered In Tram
Feb 1, 2014
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
